Measuring tumor DNA in blood for HPV-positive throat cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study looks at a blood test that finds DNA from HPV-related throat tumors. It may help doctors decide on surgery and check if the cancer is completely removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have squamous cell cancer of the throat (tonsil, tongue base, soft palate, or throat walls).
- Your tumor is HPV-positive, confirmed by a test.
- The blood test must show tumor DNA before surgery.
- Your tumor is a size T1, T2, or selected T3, and it can be removed with surgery.
- You have not had radiation or cancer in the head or neck in the last 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for certain markers in people with HPV-related throat cancer that could help doctors choose the best treatment. If you are planning to have surgery for your throat cancer, you may be able to join.
This Phase 2 study tests a “risk-adapted” treatment plan for HPV-related throat cancer, using an HPV DNA blood test to help decide how treatment is done. If your baseline blood test shows detectable HPV DNA, the study may help tailor therapy to your risk and potentially improve outcomes while limiting unnecessary treatment.
This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.
This trial tests if monitoring cancer DNA left in your blood after surgery can help decide if you need additional treatment. It is for people with HPV-positive oropharynx (throat) cancer who have a certain amount of cancer DNA detected before surgery.
This study checks a substance called HPV DNA in your blood to see how your HPV-positive throat cancer responds early during treatment. It may help doctors spot who is responding well and who may need closer attention sooner.
This study tests whether a blood test that looks for circulating HPV DNA (ctDNA) can help doctors decide if you need chemotherapy after surgery for HPV-positive throat cancer. After you have surgery to remove the cancer, you receive radiation (possibly with chemotherapy) — the results of the blood test guide whether or not to add chemo.
Hear when a new Throat Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.